Browse by UCL Departments and Centres
![]() | Up a level |
Group by: Author | Type
Number of items: 34.
A
Aamdal, S;
Lee, SM;
Radford, JA;
Thatcher, N;
Calabresi, F;
Israels, SP;
Kerger, J;
... Gerard, B; + view all
(1991)
Sequential administration of dacarbazine and fotemustine in disseminated melanoma.
In:
(Proceedings) 1991 AACR Annual Meeting/82nd Annual Meeting, Houston, TX..
(pp. 191-).
Proc Am Assoc Cancer Res
|
Abbasi, AM;
Chester, KA;
MacPherson, AJS;
Boxer, G;
Begent, RHJ;
Malcolm, ADB;
(1991)
Comparison of messenger-RNA and protein expression for carcinoembryonic antigen(CEA)in tissue-section of normal colorectal mucosa and colonic adenocarcinoma.
In:
(pp. A176-A176).
|
B
BAGSHAWE, KD;
SHARMA, SK;
SPRINGER, CJ;
ANTONIW, P;
BODEN, JA;
ROGERS, GT;
BURKE, PJ;
... SHERWOOD, RF; + view all
(1991)
ANTIBODY DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - CLINICAL REPORT.
In:
(Proceedings) WORKSHOP ON MONOCLONAL ANTIBODIES IN BREAST AND OVARIAN CANCER.
(pp. pp. 233-238).
ASFRA
|
BAGSHAWE, KD;
SHARMA, SK;
SPRINGER, CJ;
ANTONIW, P;
ROGERS, GT;
BURKE, PJ;
MELTON, R;
(1991)
ANTIBODY-ENZYME CONJUGATES CAN GENERATE CYTOTOXIC DRUGS FROM INACTIVE PRECURSORS AT TUMOR SITES.
ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS
, 4
(4)
pp. 915-922.
|
BOWER, M;
STEIN, RC;
HEDLEY, A;
DAVENPORT, J;
COLSTON, K;
COOMBES, RC;
(1991)
THE USE OF NASAL CALCITONIN SPRAY IN THE TREATMENT OF HYPERCALCEMIA OF MALIGNANCY.
CANCER CHEMOTHERAPY AND PHARMACOLOGY
, 28
(4)
pp. 311-312.
|
C
CALVERT, AH;
NEWELL, DR;
BALMANNO, K;
PEARSON, AD;
PRICE, L;
KIER, M;
(1991)
PHARMACOKINETICS OF CARBOPLATIN IN CHILDREN AND THE DEVELOPMENT OF A PEDIATRIC DOSE EQUATION.
PLATINUM AND OTHER METAL COORDINATION COMPOUNDS IN CANCER CHEMOTHERAPY
335 - 343.
|
CALVERT, AH;
URIE, J;
(1991)
THE COSTS OF CARBOPLATIN TREATMENT.
SEMIN ONCOL
, 18
(1)
28 - 31.
|
Cooper, DP;
O'Connor, PJ;
Davies, J;
Thatcher, N;
Lee, SM;
(1991)
Alkylation of lymphocyte DNA during chemotherapy with DTIC.
In:
(pp. 32-).
|
D
DAWSON, PM;
BLAIR, SD;
BEGENT, RHJ;
KELLY, AMB;
BOXER, GM;
THEODOROU, NA;
(1991)
THE VALUE OF RADIOIMMUNOGUIDED SURGERY IN 1ST AND 2ND LOOK LAPAROTOMY FOR COLORECTAL-CANCER.
DIS COLON RECTUM
, 34
(3)
217 - 222.
|
Davis, CL;
Whelan, JS;
Leahy, M;
MacCullum, P;
Norton, AJ;
Amess, JAL;
Rohatiner, AZS;
(1991)
Intermediate dose cytosine arabinoside and etoposide for the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma.
In:
|
E
EVANS, C;
STEIN, RC;
DAVENPORT, J;
DOUGHERTY, L;
CARRUTHERS, L;
COOMBES, RC;
(1991)
COMPARISON OF ONDANSETRON WITH DEXAMETHASONE AND DOMPERIDONE IN THE PROPHYLAXIS OF NON-CISPLATIN CHEMOTHERAPY INDUCED EMESIS REFRACTORY TO DEXAMETHASONE.
EUROPEAN JOURNAL OF CANCER
, 27
(3)
pp. 302-303.
10.1016/0277-5379(91)90532-I.
|
H
HARMSEN, MC;
TOLNER, B;
KRAM, A;
GO, SJ;
DEHAAN, A;
WESSELS, JGH;
(1991)
SEQUENCES OF 3 DSRNAS ASSOCIATED WITH LA FRANCE DISEASE OF THE CULTIVATED MUSHROOM (AGARICUS-BISPORUS).
CURR GENET
, 20
(1-2)
137 - 144.
|
HAYNES, BP;
JARMAN, M;
DOWSETT, M;
MEHTA, A;
LONNING, PE;
GRIGGS, LJ;
JONES, A;
... COOMBES, RC; + view all
(1991)
PHARMACOKINETICS AND PHARMACODYNAMICS OF THE AROMATASE INHIBITOR 3-ETHYL-3-(4-PYRIDYL)PIPERIDINE-2,6-DIONE IN PATIENTS WITH POSTMENOPAUSAL BREAST-CANCER.
CANCER CHEMOTHERAPY AND PHARMACOLOGY
, 27
(5)
pp. 367-372.
10.1007/BF00688859.
|
HOCHHAUSER, D;
HARRIS, AL;
(1991)
DRUG-RESISTANCE.
BRIT MED BULL
, 47
(1)
178 - 196.
|
J
JACKMAN, AL;
NEWELL, DR;
GIBSON, W;
JODRELL, DI;
TAYLOR, GA;
BISHOP, JA;
HUGHES, LR;
(1991)
THE BIOCHEMICAL PHARMACOLOGY OF THE THYMIDYLATE SYNTHASE INHIBITOR, 2-DESAMINO-2-METHYL-N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID (ICI-198583).
BIOCHEM PHARMACOL
, 42
(10)
1885 - 1895.
|
JODRELL, D;
FORREST, A;
HAWTOF, J;
GRAHAM, M;
CALVERT, AH;
EGORIN, M;
(1991)
THE POPULATION PHARMACOKINETICS OF CI941, A NOVEL ANTHRAPYRAZOLE ANTICANCER AGENT.
CLIN PHARMACOL THER
, 49
(2)
195 - 195.
|
JODRELL, DI;
NEWELL, DR;
GIBSON, W;
HUGHES, LR;
CALVERT, AH;
(1991)
THE PHARMACOKINETICS OF THE QUINAZOLINE ANTIFOLATE ICI D1694 IN MICE AND RATS.
CANCER CHEMOTH PHARM
, 28
(5)
331 - 338.
|
JODRELL, DI;
NEWELL, DR;
MORGAN, SE;
CLINTON, S;
BENSTED, JPM;
HUGHES, LR;
CALVERT, AH;
(1991)
THE RENAL EFFECTS OF N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID (CB3717) AND A NON-NEPHROTOXIC ANALOG ICI D1694, IN MICE.
BRIT J CANCER
, 64
(5)
833 - 838.
|
L
LEENHOUTS, KJ;
TOLNER, B;
BRON, S;
KOK, J;
VENEMA, G;
SEEGERS, JFML;
(1991)
NUCLEOTIDE-SEQUENCE AND CHARACTERIZATION OF THE BROAD-HOST-RANGE LACTOCOCCAL PLASMID PWVO1.
PLASMID
, 26
(1)
55 - 66.
|
Lee, SM;
Fan, CY;
Rafferty, JA;
Potter, PM;
O'Connor, PJ;
Margison, GP;
(1991)
Anti-human 06-alkylguanine-DNA-alkyltransferase antibodies show cellular heterogeneity and predominantly nuclear staining in normal and tumour tissue.
In:
(Proceedings) BACR/ACP Annual Meeting, Manchester..
(pp. 64-).
British Journal of Cancer
|
Lee, SM;
Shelbourn, SL;
Thatcher, N;
(1991)
Sequential DTIC and fotemustine in the treatment of metastatic melanoma.
In:
(Proceedings) ECCO 6/Sixth European Conference on Clinical Oncology, Firenze, Italy..
(pp. S160-).
European Journal of Cancer
|
Lee, SM;
Thatcher, N;
Margison, GP;
(1991)
06-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following DTIC and fotemustine.
In:
(pp. 33-).
|
Lee, SM;
Thatcher, N;
Margison, GP;
(1991)
06-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine.
Cancer Research
, 51
(2)
pp. 619-623.
|
Lee, SM;
Thatcher, N;
Margison, GP;
(1991)
Activity of 06-alkylguanine-DNA alkyltransferase following sequential dacarbazine (DTIC) and fotemustine.
In:
(Proceedings) BACR/ACP Annual Meeting, Manchester..
(pp. 49-).
British Journal of Cancer
|
M
MARSHAM, PR;
HUGHES, LR;
JACKMAN, AL;
HAYTER, AJ;
OLDFIELD, J;
WARDLEWORTH, JM;
BISHOP, JAM;
... CALVERT, AH; + view all
(1991)
QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITORS - HETEROCYCLIC BENZOYL RING MODIFICATIONS.
J MED CHEM
, 34
(5)
1594 - 1605.
|
MARSHAM, PR;
JACKMAN, AL;
HAYTER, AJ;
DAW, MR;
SNOWDEN, JL;
OCONNOR, BM;
BISHOP, JAM;
... HUGHES, LR; + view all
(1991)
QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITORS - BRIDGE MODIFICATIONS AND CONFORMATIONALLY RESTRICTED ANALOGS IN THE C2-METHYL SERIES.
J MED CHEM
, 34
(7)
2209 - 2218.
|
S
SHARMA, SK;
BAGSHAWE, KD;
SPRINGER, CJ;
BURKE, PJ;
ROGERS, GT;
BODEN, JA;
ANTONIW, P;
... SHERWOOD, RF; + view all
(1991)
ANTIBODY DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - A 3 PHASE SYSTEM.
In:
(Proceedings) WORKSHOP ON MONOCLONAL ANTIBODIES IN BREAST AND OVARIAN CANCER.
(pp. pp. 225-231).
ASFRA
|
SPRINGER, CJ;
BAGSHAWE, KD;
SHARMA, SK;
SEARLE, F;
BODEN, JA;
ANTONIW, P;
BURKE, PJ;
... MELTON, RG; + view all
(1991)
ABLATION OF HUMAN CHORIOCARCINOMA XENOGRAFTS IN NUDE-MICE BY ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) WITH 3 NOVEL COMPOUNDS.
EUROPEAN JOURNAL OF CANCER
, 27
(11)
pp. 1361-1366.
10.1016/0277-5379(91)90010-B.
|
STEIN, RC;
CANNON, S;
CASSONI, A;
PRINGLE, JS;
STOKER, DJ;
SOUHAMI, RL;
(1991)
CLINICAL ONCOLOGY - CASE PRESENTATIONS FROM ONCOLOGY CENTERS .1. EWINGS-SARCOMA - THE LONDON BONE-TUMOR SERVICE.
EUROPEAN JOURNAL OF CANCER
, 27
(11)
pp. 1525-1533.
10.1016/0277-5379(91)90042-C.
|
Stein, RC;
(1991)
Initial studies of 4-hydroxyandrostenedione in premenopausal patients with advanced breast cancer.
In: Coombes, RC and Dowsett, M, (eds.)
4-hydroxyandrostenedione: a new approach to hormone-dependent cancer.
(pp. 35-39).
Royal Society of Medicine
|
T
TALBOT, DC;
SMITH, IE;
MANSI, JL;
JUDSON, I;
CALVERT, AH;
ASHLEY, SE;
(1991)
ANTHRAPYRAZOLE CI941 - A HIGHLY-ACTIVE NEW AGENT IN THE TREATMENT OF ADVANCED BREAST-CANCER.
J CLIN ONCOL
, 9
(12)
2141 - 2147.
|
THORNTON, TJ;
JONES, TR;
JACKMAN, AL;
FLINN, A;
OCONNOR, BM;
WARNER, P;
CALVERT, AH;
(1991)
QUINAZOLINE ANTIFOLATES INHIBITING THYMIDYLATE SYNTHASE - 4-THIO-SUBSTITUTED ANALOGS.
J MED CHEM
, 34
(3)
978 - 984.
|
W
WHITE, LA;
NOBLES, JA;
LEE, M;
HARTLEY, JA;
(1991)
SYNTHESIS OF AN AMIDINE LINKED ANALOG OF DISTAMYCIN-A AND ITS DNA-BINDING PROPERTIES.
In:
(pp. 77-ORGN).
AMER CHEMICAL SOC
|
Whelan, JS;
Phear, GA;
Rohatiner, AZS;
Lister, TA;
Meuth, M;
(1991)
DNA sequence determination of CTP synthetase mutations in ara C-resistant hamster cells.
In:
|